Progress in Diagnosis and Treatment of Neonatal Sepsis: A Review Article

Authors

  • Pratibha Yadav Department of Pediatrics, Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, People's Republic of China
  • Shailendra Kumar Yadav Trishuli Hospital, Bidur, Nuwakot, Nepal https://orcid.org/0000-0001-6638-5503

DOI:

https://doi.org/10.31729/jnma.7324

Keywords:

cytokines; immunoglobulin; neonatal sepsis; procalcitonin.

Abstract

Neonatal sepsis is a serious condition in which the pathogens infiltrate the bloodstream, multiply and produce toxins causing deleterious effects to the health of neonates. It is divided into two types on the basis of the time of onset. Early onset sepsis occurs within 72 hours of birth and late onset sepsis begins after 72 hours of delivery. Neonatal sepsis continues to be a common and significant health care burden, especially in very low birth weight infants (with birthweight less than 1500 grams). Though intrapartum antibiotic prophylaxis has decreased the incidence of early-onset group B streptococcal infection dramatically, it still remains a major cause of neonatal sepsis. As the signs and symptoms of neonatal sepsis are nonspecific, early diagnosis and prompt treatment remain a challenge.

Downloads

Published

2022-03-11

How to Cite

Yadav, P. ., & Kumar Yadav, S. . (2022). Progress in Diagnosis and Treatment of Neonatal Sepsis: A Review Article. Journal of Nepal Medical Association, 60(247), 318–324. https://doi.org/10.31729/jnma.7324